Thomas Verghese Email & Phone Number

Houston, TX, US

Singapore, SG

Sydney, NSW, AU

Frankfurt, DE

• Chair - Operations SubCommittee

Metairie, Louisiana, US

• Audit Committee Chairman
• Post Financial Restructuring

Metairie, Louisiana, US

• Littlejohn Portfolio Company
• Member of Audit Committee
• Catalyzed $50m+ Operational Value Creation and Entitlement Program; Member of Maintenance / Reliability & Value Creation Steering Committees

• OpenGate Capital Portfolio Company
• Formed through the merger of
• ChemSolv, Inc - headquartered in Roanoke, Virginia (Acquired December 2021)
• Chemisphere Corporation - headquartered in St. Louis, Missouri (Acquired December 2021)

Riverside, California, US

Saint-Priest, FR

• PE Industry Executive for Littlejohn, a mid-cap PE company, retained to advise on Chemicals/Materials investment thesis and transactions
• Completed sixteen (16) acquisitions with PE partners or Strategics. Total EV ~$8.0bn.
• Worked with private equity partners (Lone Star Funds, HIG Capital, Advent, American Securities, Littlejohn, TPG, OpenGate and others) on multiple investment theses, auctions and value creation.
• Board Member for Whitesquare Chemical, an early-stage inorganic polymer company (2107 - 2021)
• Operating Partner for Dalfort Capital, independent sponsor active in Chemicals and Industrials (2017 - 2020)
• Chairman of Board for Magna Imperio (MI) Systems, a desalination/water technology start-up (2016 - 2017)

Belle, West Virginia, US

• Littlejohn portfolio company
• Exit to Arclin, portfolio company of The Jordan Company

Kansas City, Kansas, US

• Investor & Executive Chairman then CEO. Mid market Specialty Coatings Company.
• Portfolio Company of Dalfort Capital, independent sponsor
• Completed three (3) buy and build acquisitions - Raven Lining Systems, Milamar & SPI
• Sold to PPG - ~10x MOIC

Houston, Texas, US

• Report to CEO, PE Operating Partner, and key shareholder of $3B+ portfolio company of private equity firm, SK Capital Partners; global manufacturer / distributor of chemicals and plastics. Delivered immediate growth in.
• Energized the business and delivered dramatic business improvements in resource-constrained environment through clear vision / goal setting, organizational restructuring, team building, accountability, disciplined.
• Moved decisively to grow revenues by capturing new opportunities and retaining business. Increased volume >20% through organic growth in all product lines, negotiating new long-term agreement with major customer, and.
• Increased EBITDA 2.5X, dramatically increased business cash flow, and drove operational improvements across reliability, capacity, production and safety.
• Architected ambitious, forward-looking growth strategies to drive long term value creation: industry restructuring strategies; product repositioning to improve profitability; new, value-added specialty chemicals.

Chicago, US

• Joined executive team of $2.3B business within $18B global manufacturer of imaging equipment, medical devices and clinical systems. Built and led a 50-member team and reported to the CEO & President. Defined business.
• Drove double digit order growth and increased market share over 3 years.
• Developed new growth streams: Grew high-margin software business 10X and expanded into new market segments via acquisition of specialty scanner company.
• Dramatically increased focus on emerging markets, increasing contribution from 25% to 41% of total sales.
• Led 6 major products / services launches generating over $1B in cumulative orders.

Boston, MA, US

• Promoted to GE’s global corporate marketing team and charged with identifying opportunities to accelerate growth across emerging markets. Served on Global Marketing Council and reported to GE’s CMO.
• Developed “Reverse Innovation” framework in collaboration with Dartmouth Tuck School of Business professor to improve new product development in emerging markets. Launched concept and toolkit across GE.
• Operationalized “Reverse Innovation” in GE Healthcare India; identified strategies to increase sales growth rate 3X. Delivered commercial support to GE India for 1-year sales increase of 84%.
• Innovation framework became subject of Harvard Business School case study and catalyzed additional product development projects in Brazil, India, China, and Africa with $5-10B revenue potential across all GE industrial.

Boston, MA, US

• Recruited to lead the start-up of a new business segment operating within $7B global industrial division (divested in 2007 to SABIC, one of the largest chemical/industrial manufacturers in the world).
• Obtained $5M in seed funding to transform a CEO “Innovation Breakthrough” program into a high-growth business. Built a 30-person cross-functional team, and established functional capabilities
• Recommended and received Board approval to discontinue high profile resin program; delivered adjacent revenues of >$20M and packaged intellectual property for licensing.

US

Formerly a Top 5 global business and $25B UK-based company with interests in chemicals, paints, advanced materials, electronic materials, pharmaceuticals (now part of AstraZeneca), and fragrances/flavors (now part of Guivaudan); acquired by AkzoNobel in 2007.Advanced through series of executive positions within $3.3B global coatings manufacturer and.

Honed operations, marketing and commercial leadership during a period of business carve-out, globalization, new market entry, and profitability improvement for a $350M segment producing/marketing automotive refinish coatings. Developed strategic plan shifting North America from loss to break-even in 3 years while accelerating sales 75%. Improved.

Mba, Business Administration

Ph.D., Chemical Engineering

M.A. & B.A., Chemical Engineering